Training courses & Webinars:

Biopharmaceuticals, known colloquially as biopharma, are the point at which biotechnology and pharmaceutical manufacturing meet. Biopharma is the application of living organisms or extractions, by-products or components of living organisms, to prevent, relieve, or treat diseases.

Management Forum’s biopharma training courses provide an extensive series of training opportunities covering a variety of topics, including the development of biopharmaceuticals, clinical trial requirements, manufacture, regulations and applicable standards. Our courses also provide insight into the use of emerging technologies and state-of-the-art processes.  


Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book

Biosimilars Training Course


1-2 Oct 2024 - Online webinar
Also on: 30 Jan 2025

A two-day seminar providing an essential overview of biosmilars and how they differ from the original biological product.

Presented by Andrew Willis (bio)

More @ IPI Academy

Biotechnology for the Non-Biotechnologist Training Course

Biotechnology for the Non-Biotechnologist

25-27 Sep 2024 - London
Also on: 2 Dec 2024

An ideal course for non-scientists and scientists who need to understand the basic theory, principles, techniques and potential of biotechnology.

Presented by Suzanne Aldington (bio)
and 6 more leading experts

More @ IPI Academy

Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products Training Course

Chemistry, Manufacture and Control (CMC) - Regulatory Requirements for Biological Drug Products

17-18 Oct 2024 - Online webinar
Also on: 27 Feb 2025

The regulatory requirements for Biological drug products are complex, and pharmaceutical companies are continuously under pressure to ensure regulatory compliance from drug discovery to post-marketing surveillance.
This course has been designed to help you navigate the complex regulatory requirements for biological drugs, including ATMPs. It will clearly depict the differences between small and large molecules and the development approaches which reflect the type of molecule. It will address the key aspects of the CTD, look at the CMC regulatory requirements during different stages of development, and discuss the importance of change control.

Presented by Andrew Willis (bio)

More @ IPI Academy

Delivery of Biologics to the Nasal Cavity Training Course

Delivery of Biologics to the Nasal Cavity

8 Oct 2024 - Online webinar

The nasal cavity is an established pathway to treat local diseases as well as systemic conditions using small molecules. As the pharmaceutical industry shifts towards targeted biologics, the nasal cavity is also an attractive target for delivery of peptides, monoclonal antibodies, nucleic acids and stem cells. This is an ideal opportunity to hear from experts in the field of nasal drug delivery who will address topics such as: challenges associated with formulation, barriers to cell penetration and absorption, the pros and cons for liquid versus powder formulations, and strategies for maintaining stability and prolonging retention in the nasal cavity.

Presented by Gemma Budd (bio)
and 3 more leading experts

More @ IPI Academy

US FDA (Food and Drug Administration) - Understanding Key Factors When Working with the FDA (Food and Drug Administration) Training Course

US FDA - Understanding Key Factors When Working with the FDA

27 Nov 2024 - Online webinar
Also on: 13 Mar 2025

This course has been designed to provide an essential overview of the critical factors when working with the FDA (Food and Drug Administration).  For those short on time this course is for you, as you will receive a focused and comprehensive overview of the key strategic considerations when making applications to the FDA.  

Presented by Andrew Willis (bio)

More @ IPI Academy

I wanted to get short insight into biosimilar development process and I completely accomplished it.

Ainars Gavarans, , Olainfarm AS

Content was informative, I've learned many new details and subjects to consider. Speaker was fluent and interactive. I'll recommend this course to new QP's in the future.

Lian Abu-Obed, QP Trainee, Unipharm Limited

The speaker had lots of clarity in his explanations, making the course very easy to follow and understand, even with deep topics.

Bernardo Diaz, Regulatory Affairs Manager, Bioeq AG

Very clear and informative!

Serge PAMPFER, CEO, Maedia

I thought all the speakers were excellent. You could tell that they all really knew there subject matter and were so passionate in the way they delivered the content. Special mention has to go to Adekunle - fantastic course leader and so knowledgeable and made the 3 days very interactive.

Mark Kalinowski, Chief Financial officer, Albumedix Ltd

The webinar had enough information for anyone to start their CMC biologics career or who is interested to do so. Or even for someone with biologics experience is looking to have additional knowledge and information can attend this training.
Andrew's knowledge and experience was proven very well.

Vineet Gavankar, Manager, Regulatory Affairs, PharmaLex UK Services Limited

The course was good and it was a pleasure to learn from the speakers. I wanted to get an overview of research and development of drugs and pharmaceuticals. I think this was achieved.

Sarah Kanna, Senior Legal Associate, Hevolution Foundation

Webinar was good, informative and lots of information. Speakers are well knowledgeable about Biosimilar Industry.

Srikanth Varma Kc, Global Audit and Due Diligence QA Manager, Abbott

It felt comprehensive.
An excellent resource going forward.

James McCracken, Quality Audit Manager , Advanz Pharma

The speaker was very good, the slides were clear and the explanations exhaustive.

Chiara Giaconi, Global Regulatory Affairs Oncology CMC Manager, Menarini Ricerche S.p.A.